The Wound Microbiome: Modern Approaches to Examining the Role of Microorganisms in Impaired Chronic Wound Healing

Ana M Misic, Sue E Gardner, Elizabeth A Grice, Ana M Misic, Sue E Gardner, Elizabeth A Grice

Abstract

Significance: Bacterial burden is believed to play a significant role in impaired wound healing of chronic wounds and the development of infection-related complications. The standard of care in the clinic relies upon cultivation-dependent methods to identify microorganisms. These assays are biased toward microorganisms that thrive in isolation under laboratory conditions. Recent Advances: Significant advances in genomic technologies have enabled less-biased, culture-independent approaches to characterize microbial communities, or microbiomes. The aggregate sequencing and analysis of 16S ribosomal RNA genes has demonstrated that cultures under-represent true microbial diversity and load. Critical Issues: Despite recent advances that enable culture-independent analyses of microbiomes, those organisms that are important in impaired healing remain ambiguous. Inconsistent findings across various studies highlight the need to characterize microbiomes of chronic wounds with homogenous etiology to determine differences in microbiomes that may be driven by the wound environment and that may affect wound outcomes. Rigorous analyses of wound microbiomes in light of the three dimensions of bioburden (microbial diversity, microbial load, and pathogenic organisms), clinical metadata, and wound outcomes will be a significant step forward in our quest to understand the role of microorganisms in impaired healing. Future Directions: Longitudinal studies employing serial sampling are needed to appreciate the role of the dynamic microbial community in chronic wound healing. The value of clinical metadata needs to be examined as potential biomarkers of problematic microbiota and wound outcomes. Lastly, better characterization and understanding of wound microbiomes will open avenues for improved diagnostic and therapeutic tools for the nonhealing wound.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4086514/bin/fig-6.jpg
Elizabeth A. Grice, PhD
Figure 1.
Figure 1.
The workflow of a 16S ribosomal RNA (16S rRNA) gene targeted microbiome next-generation sequencing project. A heterogeneous mixture of genomic DNA is extracted from samples taken from a wound. Primers specific for the desired regions of the 16S rRNA gene are used to amplify bacterial DNA. Each sample has a unique identifying sequence on the primer known as a barcode to facilitate the multiplexing of samples on the sequencer. The resulting polymerase chain reaction (PCR) products are pooled and sequenced using platforms, such as Roche 454, Illumina MiSeq, or Life Technologies Ion Torrent. After filtering out low-quality sequences, various analyses are performed, including assignment to taxonomy, analysis of shared phylogeny, and analysis of microbial community membership, structure, and diversity. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/wound
Figure 2.
Figure 2.
Model of the impact of three dimensions of bioburden and nonmicrobial factors on wound outcomes. The three dimensions of bioburden are covarying components of the wound microbiome. We propose that the microbiome is one of several factors that lead to ultimate wound outcomes, such as healing or the development of infection-related complications.
Figure 3.
Figure 3.
16S rRNA gene sequencing-based methods provide a more comprehensive view of bacterial diversity compared to culture-based methods. A comparison of bacterial diversity assessed by culture-based and 16S rRNA gene sequencing results. The symbols represent the mean bacterial taxa count per sample included in each study. In Price et al., the number of cultured genera was compared to the number of sequenced genera. In Han et al., the number of cultured species was compared to the number of sequenced genera. In Gardner et al., the number of cultured species was compared to the number of sequenced species. The horizontal line indicates the mean of the three studies surveyed. References to each study are denoted in brackets.
Figure 4.
Figure 4.
The 10 most abundant bacterial genera observed in select chronic wound microbiome publications. Each large circle represents the top 10 most abundant genera reported from the publication indicated. Only the top 10 most abundant genera are included. Staphylococcus, Corynebacterium, and Anaerococcus were common to the 10 most abundant genera in all three studies. “Unc.” denotes unclassified bacteria. *Denotes strictly anaerobic or obligately anaerobic bacteria. References to each study are denoted in brackets. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/wound
Figure 5.
Figure 5.
Bacterial families reported to colonize chronic wounds in culture-independent studies. Twenty-one bacterial families account for the majority of microbiota colonizing chronic wounds in five studies utilizing culture-independent methods. The bacterial phyla Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, and Fusobacteria are represented. Here, we show the results of these publications as relative abundance charts, with the etiology of the wounds, and the method of collection noted. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/wound

References

    1. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, and Bradley L: The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007; 9:665.
    1. Rice LB: Mechanisms of resistance and clinical relevance of resistance to beta-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc 2012; 87:198.
    1. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
    1. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. : Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54:1679.
    1. Bowler PG. and Davies BJ: The microbiology of infected and noninfected leg ulcers. Int J Dermatol 1999; 38:573.
    1. Gardner SE. and Frantz RA: Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 2008; 10:44.
    1. Martin JM, Zenilman JM, and Lazarus GS: Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2010; 130:38.
    1. Davies CE, Wilson MJ, Hill KE, Stephens P, Hill CM, Harding KG, and Thomas DW: Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 2001; 9:332.
    1. Bowler PG, Duerden BI, and Armstrong DG: Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14:244.
    1. Hugenholtz P. and Pace NR: Identifying microbial diversity in the natural environment: a molecular phylogenetic approach. Trends Biotechnol 1996; 14:190.
    1. Cole JR, Chai B, Farris RJ, Wang Q, Kulam-Syed-Mohideen AS, McGarrell DM, Bandela AM, Cardenas E, Garrity GM, and Tiedje JM: The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res 2007; 35 (Database issue):D169.
    1. Robson MC, Mannari RJ, Smith PD, and Payne WG: Maintenance of wound bacterial balance. Am J Surg 1999; 178:399.
    1. Gardner SE, Hillis SL, Heilmann K, Segre JA, and Grice EA: The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 2013; 62:923.
    1. Han A, Zenilman JM, Melendez JH, Shirtliff ME, Agostinho A, James G, Stewart PS, Mongodin EF, Rao D, Rickard AH, and Lazarus GS: The importance of a multifaceted approach to characterizing the microbial flora of chronic wounds. Wound Repair Regen 2011; 19:532.
    1. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, Bowers J, Rattray R, Ravel J, Kingsley C, Keim PS, Lazarus GS, and Zenilman JM: Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 2009; 4:e6462.
    1. Price LB, Liu CM, Frankel YM, Melendez JH, Aziz M, Buchhagen J, Contente-Cuomo T, Engelthaler DM, Keim PS, Ravel J, Lazarus GS, and Zenilman JM: Macroscale spatial variation in chronic wound microbiota: a cross-sectional study. Wound Repair Regen 2011; 19:80.
    1. Wolcott RD, Gontcharova V, Sun Y, and Dowd SE: Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 2009; 9:226.
    1. Frank DN, Wysocki A, Specht-Glick DD, Rooney A, Feldman RA, St. Amand AL, Pace NR, and Trent JD: Microbial diversity in chronic open wounds. Wound Repair Regen 2009; 17:163.
    1. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, and Wolcott RD: Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008; 8:43.
    1. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, and Rhoads D: Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008; 3:e3326.
    1. Gardner SE, Frantz RA, and Doebbeling BN: The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 2001; 9:178.
    1. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, Gevers D, and Knight R: Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 2012; 13:47.
    1. Levine NS, Lindberg RB, Mason AD, Jr, and Pruitt BA, Jr: The quantitative swab culture and smear: a quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma 1976; 16:89.
    1. Gardner SE, Frantz RA, Saltzman CL, Hillis SL, Park H, and Scherubel M: Diagnostic validity of three swab techniques for identifying chronic wound infection. Wound Repair Regen 2006; 14:548.
    1. Christman AL, Selvin E, Margolis DJ, Lazarus GS, and Garza LA: Hemoglobin A1c predicts healing rate in diabetic wounds. J Invest Dermatol 2011; 131:2121.
    1. Adler AI, Boyko EJ, Ahroni JH, and Smith DG: Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22:1029.
    1. Adam KM, Mahmoud SM, Mahadi SI, Widatalla AH, Shawer MA, and Ahmed ME: Extended leg infection of diabetic foot ulcers: risk factors and outcome. J Wound Care 2011; 20:440.
    1. Grice EA, Snitkin ES, Yockey LJ, Bermudez DM, Liechty KW, and Segre JA: Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc Natl Acad Sci USA 2010; 107:14799.
    1. Barnett A, Dave B, Ksander GA, and Vistnes LM: A concentration gradient of bacteria within wound tissues and scab. J Surg Res 1986; 41:326.
    1. Margolis DJ, Allen-Taylor L, Hoffstad O, and Berlin JA: Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med 2003; 115:627.
    1. Margolis DJ, Kantor J, Santanna J, Strom BL, and Berlin JA: Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 2000; 136:1531.

Source: PubMed

3
구독하다